Aspen Pharmacare Holdings Limited

As of December 31, 2025, Aspen Pharmacare Holdings Limited carries a market capitalization of 5.19T, placing it among publicly traded companies globally. Its enterprise value stands at 7.92T, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Aspen Pharmacare Holdings Limited's next confirmed earnings release is scheduled for March 11, 2027.

As of December 31, 2025, Aspen Pharmacare Holdings Limited has 444.02M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Aspen Pharmacare Holdings Limited maintains a current ratio of 3.64, meaning it holds 3.6x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, Aspen Pharmacare Holdings Limited's stock has gained approximately 56.44% over the past 52 weeks. The 50-day moving average sits at 15,496.66, while the 200-day moving average is 14,092.20.

As of December 31, 2025, Aspen Pharmacare Holdings Limited holds 562.00B in cash and equivalents against 3.29T in total debt, resulting in a net debt position of 2.73T. Total book value stands at 8.11T, with working capital of 4.16T providing operational flexibility.

Aspen Pharmacare Holdings Limited's most recent stock split took place on October 6, 2008 with a 400:407 split ratio.